Neuroone Medical Technologies is trading 5.4% down at $1.57; no clear company-specific announcement or event explains the decline.
- A September 9 conference report highlighted growth opportunities but identified no negative catalyst for the September 10, 2026, move.
- Broader markets are also lower amid hotter wholesale inflation, though index declines remain moderate.